{"id":"W2606398981","doi":"10.1016/s0140-6736(17)30570-6","title":"Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":446,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Crohn's disease; Internal medicine; Placebo; Gastroenterology; Population; Ileitis; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004610545,0.0002937099,0.0004025265,0.00004445731,0.0005040942,0.0002311703,0.0006365986,0.00006489065,0.00001054349],"category_scores_gemma":[0.00006539015,0.000142681,0.00007157091,0.00007061315,0.000145433,0.00002654272,0.000111255,0.0002331311,0.000009260858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004738958,"about_ca_system_score_gemma":0.0001712098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002795669,"about_ca_topic_score_gemma":0.0003468638,"domain_scores_codex":[0.9984056,0.0003104255,0.0002129933,0.0004373814,0.0002852624,0.0003482752],"domain_scores_gemma":[0.9982334,0.00002467186,0.0002491764,0.001206202,0.0001757237,0.0001108462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9647567,0.0007578398,0.03084393,0.000006915141,0.0003789365,0.0000524239,0.0008007449,0.0006469134,0.0002113021,0.000005980564,0.001048665,0.0004897013],"study_design_scores_gemma":[0.665101,0.0009644276,0.3324572,0.00003023753,0.0000976065,0.000001439439,0.0002234759,0.00007198151,0.0005641638,0.00001710662,0.0001952668,0.0002761053],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928645,0.00004366712,0.00004530663,0.0005061504,0.00009035484,0.006096533,0.0000390648,0.00001867211,0.0002957082],"genre_scores_gemma":[0.9973063,0.000007821609,0.00001233097,0.0003042195,0.0005445521,0.001523967,0.00005022635,0.00004110239,0.0002094672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3016133,"threshold_uncertainty_score":0.5818364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01638400138012186,"score_gpt":0.2788584941830377,"score_spread":0.2624744928029158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}